non alcoholic steatohepatitis
Showing 1 - 25 of 33
Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Fecal Microbiota Transplantation Trial in Amsterdam
Recruiting
- Non Alcoholic Steatohepatitis
- +8 more
- LFMT-capsules
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC
Apr 6, 2023
Non Alcoholic Steatohepatitis Trial in Tanta (Pioglitazone 30mg, Empagliflozin 10 MG)
Not yet recruiting
- Non Alcoholic Steatohepatitis
- Pioglitazone 30mg
- Empagliflozin 10 MG
-
Tanta, Gharbiya, EgyptTanta University
Nov 2, 2022
Non Alcoholic Steatohepatitis, Hyperuricemia Trial in Tanta (Febuxostat 80 MG Oral Tablet, vit E)
Recruiting
- Non Alcoholic Steatohepatitis
- Hyperuricemia
- Febuxostat 80 MG Oral Tablet
- vit E
-
Tanta, EgyptDepartment of Tropical Medicine and Infectious Diseases, Faculty
Oct 8, 2022
Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis, Hepatic Steatosis Trial (Fructo-oligosaccharide supplement,
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- +2 more
- Fructo-oligosaccharide supplement
- Maltodextrin
- (no location specified)
Jul 27, 2022
Non Alcoholic Steatohepatitis Trial in Roma, Rome (RYGB, SG, Intensive Lifestyle Modification)
Completed
- Non Alcoholic Steatohepatitis
- RYGB
- +2 more
-
Roma, Italy
- +2 more
Jul 20, 2022
Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)
Not yet recruiting
- Cancer Risk
- +30 more
- Samples
-
Boston, MassachusettsDana Farber Cancer Institute
Jul 14, 2022
Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis Trial in Giza (Genomics (DNA Extraction), Epi-genomics,
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Non Alcoholic Steatohepatitis
- Genomics (DNA Extraction)
- +4 more
-
Giza, Al Jizah, EgyptNational Research Centre
Jun 1, 2022
Patient Demographics, Comorbidities, and Medications on Severity
Completed
- Non-Alcoholic Fatty Liver Disease
- Non Alcoholic Steatohepatitis
- NAFLD/NASH
-
Dallas, TexasMethodist Dallas Medical Center
Apr 27, 2022
Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis Trial in Majadahonda (Fecal Microbiota Transplantation)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Non Alcoholic Steatohepatitis
- Fecal Microbiota Transplantation
-
Majadahonda, Madrid, SpainPuerta de Hierro University Hospital
Apr 13, 2022
Nonalcoholic Fatty Liver Disease (NAFLD) in Adults
Completed
- Non-Alcoholic Fatty Liver Disease
- Non Alcoholic Steatohepatitis
- non-applicable
-
Fort Sam Houston, TexasSan Antonio Military Medical Center
Mar 21, 2022
Non Alcoholic Steatohepatitis Trial in San Diego, New York (Elafibranor 80mg, Elafibranor 120mg)
Terminated
- Non Alcoholic Steatohepatitis
- Elafibranor 80mg
- Elafibranor 120mg
-
San Diego, California
- +1 more
Sep 29, 2021
Non Alcoholic Steatohepatitis Trial in Redwood City, Stanford (Idebenone, Placebo)
Recruiting
- Non Alcoholic Steatohepatitis
- Idebenone
- Placebo
-
Redwood City, California
- +1 more
Jul 16, 2021
Coffee Consumption and NASH in the French Population.
Completed
- Non Alcoholic Steatohepatitis
-
Béziers, France
- +15 more
Jan 27, 2021
Non Alcoholic Steatohepatitis Trial in United States (Saroglitazar Magnesium 2mg, Saroglitazar Magnesium 4mg, Placebos)
Completed
- Non Alcoholic Steatohepatitis
- Saroglitazar Magnesium 2mg
- +2 more
-
Jackson, Mississippi
- +5 more
Dec 11, 2020
The Role of Immune Semaphorins in NAFLD
Unknown status
- Non-Alcoholic Fatty Liver Disease
- +4 more
- Evaluation of the degree of fibrosis and steatosis
- +3 more
-
Zagreb, CroatiaUniversity Hospital for Infectious Diseases Zagreb
Sep 29, 2020
Expanding Donor Pool for Live Donor Liver Transplantation:
Completed
- Non Alcoholic Steatohepatitis
- No Intervention
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Sep 26, 2020
Non Alcoholic Steatohepatitis Trial in Tanta (Placebo, Montelukast)
Completed
- Non Alcoholic Steatohepatitis
- Placebo
- Montelukast
-
Tanta, El-Gharbia, EgyptDr. Tarek Mohamed Mostafa
Aug 30, 2020
Non Alcoholic Steatohepatitis Trial in San Diego (Ezetimibe)
Completed
- Non Alcoholic Steatohepatitis
-
San Diego, CaliforniaUniversity of California, San Diego
Jul 1, 2020
Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese
Completed
- Morbid Obesity
- Non Alcoholic Steatohepatitis
-
Colombes, FranceHôpital Louis Mourier
Dec 18, 2019
Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis, NASH - Nonalcoholic Steatohepatitis Trial (Moderate intensity
Withdrawn
- Non-Alcoholic Fatty Liver Disease
- +2 more
- Moderate intensity aerobic exercise
- (no location specified)
Nov 26, 2019
Non Alcoholic Steatohepatitis Trial in Tehran (Dietary Supplement: hesperidin and flaxseed, Dietary Supplement: hesperidin,
Unknown status
- Non Alcoholic Steatohepatitis
- Dietary Supplement: hesperidin and flaxseed
- +3 more
-
Tehran, Iran (the Islamic Republic Of), Iran, Islamic Republic ofNational Nutrition and Food Technology Research Institute
Nov 6, 2018
Non Alcoholic Steatohepatitis Trial in New Delhi (Fecal Microbiota Transplant, Standard Medical Treatment)
Unknown status
- Non Alcoholic Steatohepatitis
- Fecal Microbiota Transplant
- Standard Medical Treatment
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Feb 13, 2018
Non Alcoholic Steatohepatitis Trial in Tehran (Hesperidin, control)
Unknown status
- Non Alcoholic Steatohepatitis
- Hesperidin
- control
-
Tehran, Iran, Islamic Republic ofNational Nutrition and Food Technology Research Institute
Dec 13, 2017
Non Alcoholic Steatohepatitis Trial in Tehran (hesperidin and flaxseed, control)
Unknown status
- Non Alcoholic Steatohepatitis
- hesperidin and flaxseed
- control
-
Tehran, Iran, Islamic Republic ofNational Nutrition and Food Technology Research Institute
Dec 13, 2017